For the Inventor, By the Inventor

Enter assignee name

Kent, United Kingdom

Jazz Pharmaceuticals Research UK Limited

USPTO Granted Patents = 23

EPO Patents = 25

Trademarks = 5

Forward Citations = 51

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Geoffrey W Guy (9 out of 73 patents)

Benjamin Whalley (7 out of 20 patents)

Stephen Wright (6 out of 61 patents)

4. Volker Knappertz (5 out of 11 patents)

5. Marie Woolley-Roberts (4 out of 11 patents)

6. Kevin James Craig (4 out of 5 patents)

7. Daniel Adam Checketts (4 out of 5 patents)

8. Orrin Devinsky (3 out of 28 patents)

9. Alan Silcock (3 out of 4 patents)

10. David Critchley (2 out of 5 patents)

11. Royston Gray (2 out of 6 patents)

12. Claire Williams (2 out of 12 patents)

13. Eduardo Dunayevich (1 out of 3 patents)

14. Angus Dalgleish (1 out of 18 patents)

15. Harshit Shah (1 out of 2 patents)

23 patents: Sort by Forward Citations

1. 12740992 - Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities (2026-09-22),

2. 12678450 - Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities (2026-07-14),

3. 12661365 - Use of cannabidiol in the treatment of epilepsy (2026-06-23),

4. 12616705 - Use of cannabinoids in the treatment of Angelman syndrome (2026-05-05),

5. 12569505 - Oral solid dosage forms comprising cannabinoids (2026-03-10),

6. 12558362 - Use of cannabidiol in the treatment of seizures associated with rett syndrome (2026-02-24),

7. 12539472 - Method of preparing cannabinoids (2026-02-03),

8. 12534438 - Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof (2026-01-27),

9. 12427160 - Use of cannabinoids in the treatment of epilepsy (2025-09-30),

10. 12403136 - Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof (2025-09-02),

11. 12396963 - Cannabidiol-type cannabinoid compound (2025-08-26),

12. 12383567 - Use of cannabinoids in the treatment of epilepsy (2025-08-12),

13. 12383512 - Cannabidiol-type cannabinoid compound (2025-08-12),

14. 12364670 - Cannabidiol-type cannabinoid compound (2025-07-22),

15. 12357586 - Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy (2025-07-15),

Company Overview

Jazz Pharmaceuticals Research UK Limited is a biopharmaceutical company based in Kent, UK, focused on developing innovative treatments for patients with serious medical conditions. The organization specializes in areas such as neuroscience and oncology, aiming to address unmet medical needs through advanced research and development. By leveraging cutting-edge technologies and scientific expertise, Jazz Pharmaceuticals is committed to improving patient outcomes and enhancing the quality of life for those affected by complex diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

23 Patents

#3 in Kent

#773 in United Kingdom

#27,714 in the World

Kent, United Kingdom

Jazz Pharmaceuticals Research UK Limited

Forward Citations = 51

41 inventors:

Geoffrey W Guy (9 out of 73 patents)

Benjamin Whalley (7 out of 20 patents)

Stephen Wright (6 out of 61 patents)

4. Volker Knappertz (5 out of 11 patents)

5. Marie Woolley-Roberts (4 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jazz Pharmaceuticals Research UK Limited. Retrieved from https://idiyas.com/company/jazz-pharmaceuticals-research-uk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…